

A recent study from the University of California, San Francisco (UCSF), highlights how hormonal changes during menopause can accelerate the progression of multiple sclerosis (MS), significantly affecting patients’ mobility, cognition, and dexterity.
Key Findings from the Study
The study, published in Neurology, tracked 184 women for 13 years using data from UCSF’s EPIC and ORIGINS studies. Researchers observed:
- Mobility Declines: Postmenopausal women took longer to complete a 25-foot walk, even after accounting for age and lifestyle factors.
- Cognitive and Dexterity Impairments: Subtle declines in fine motor skills and cognitive function were observed.
- Biomarker Evidence: Higher levels of neurofilament light chain (NfL) in the blood, a marker of nerve cell degeneration, validated these findings.
The Role of Hormones in Multiple Sclerosis
Women represent 75% of multiple sclerosis patients, with hormonal changes playing a pivotal role in the disease’s trajectory.
- Puberty and MS Risk: Hormonal shifts during puberty can trigger autoimmune responses.
- Pregnancy Effects: Relapse rates drop during the third trimester of pregnancy, followed by a postpartum rebound, further underscoring the influence of hormones.
Implications for Hormone Therapy
While only 17% of study participants used estrogen therapy, this wasn’t enough to draw definitive conclusions about its efficacy. However, animal research and small human trials suggest that sex hormones, including testosterone, may have neuroprotective benefits.
What This Means for Multiple Sclerosis Patients
The study highlights menopause as a critical factor in MS progression, separate from aging. It calls for large-scale randomized trials to explore the potential benefits of hormone therapy for MS.
Practical Takeaways for MS Management
- Mobility Monitoring: Patients and doctors should monitor walking speed and dexterity during menopause.
- Biomarker Insights: Tracking neurofilament light chain levels could provide early signs of disease progression.
- Potential Role of Hormones: While promising, hormone therapy needs more research to confirm its benefits and safety.
Be a part of HerHealth Congress 2025 for more insights on women’s health.
More Information: University of California – San Francisco
more recommended stories
Can Creatine and β-Alanine Co-Supplementation Boost Athletic Performance?
A new systematic review offers insights.
Vaping and Teen Smoking: UK Study Warns of Rising Risks
A new study published in Tobacco.
Healthy Dietary Patterns Linked to Lower Chronic Disease Burden in Aging Adults
Diet and healthy aging: insights from.
Coffee and Tea Linked to Brain Health in Seniors
Coffee and cognitive performance linked to.
Yogurt Health Benefits Lead to New Insights on Dairy Foods and Chronic Disease
Fermented dairy products show the strongest.
PFAS Exposure Linked to Increased Type 2 Diabetes Risk
Investigating the Metabolic Impact of Forever.
Can Routine Vaccines Help Combat Antibiotic Resistance?
A growing body of evidence now.
T-bet and the Genetic Control of Memory B Cell Differentiation
In a major advancement in immunology,.
Brain’s Biological Age Emerges as Key Health Risk Indicator
Clinical Significance of Brain Age in.
Children’s Health in the United States is Declining!
Summary: A comprehensive analysis of U.S..
Leave a Comment